Key Highlights
•
The study found that a new once-weekly insulin formula achieved better blood sugar control with fewer hypoglycemic episodes compared to daily injections. This could simplify diabetes management for millions of patients and improve treatment adherence.
Source →
•
Researchers identified a biomarker in the gut microbiome that predicts type 2 diabetes onset up to 10 years before symptoms appear. This early detection could enable preventive interventions and reverse the disease’s progression before damage occurs.
Source →
•
A clinical trial showed that an AI-powered insulin pump system reduced average blood glucose levels by 15% more than standard therapy. This marks a major step toward fully automated diabetes management that adapts to real-time patient needs.
Source →
Stay curious. Stay informed —
Science Briefing
